BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1699189)

  • 1. Elevated sera levels of SP-1 induced by chemotherapy in patients with metastatic gestational trophoblastic diseases.
    Göcze PM; Than GN; Szabò DG; Csaba IF; Bohn H
    Oncology; 1990; 47(5):406-9. PubMed ID: 1699189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic reliability of simultaneous measurements of beta human chorionic gonadotropin and pregnancy-specific beta-1-glycoprotein in serum of patients with trophoblastic disease.
    Takayama M; Soma H; Isaka K; Okudera K; Ogawa T; Kikuchi K
    Gynecol Obstet Invest; 1987; 23(3):151-6. PubMed ID: 3036671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serum pregnancy-specific beta 1-glycoprotein to beta-human chorionic gonadotrophin ratio as an index of prognosis in patients with choriocarcinoma.
    Sakuragi N; Ohkubo H; Yamamoto R; Shiina Y; Tanaka T; Ichinoe K; Fujimoto S
    Br J Obstet Gynaecol; 1988 Jun; 95(6):614-8. PubMed ID: 2455537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
    Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study and treatment of gestational trophoblastic diseases at the John I. Brewer Trophoblastic Disease Center, 1962-1990.
    Lurain JR; Sciarra JJ
    Eur J Gynaecol Oncol; 1991; 12(6):425-8. PubMed ID: 1667098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential production of human chorionic gonadotropin and free subunits in gestational trophoblastic disease.
    Ozturk M; Berkowitz R; Goldstein D; Bellet D; Wands JR
    Am J Obstet Gynecol; 1988 Jan; 158(1):193-8. PubMed ID: 2447774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M; el-Shobokshy AS; el-Noury AI
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the indication of surgical resection of pulmonary metastasis of malignant trophoblastic tumor].
    Zhang Y; Xiang Y; Ren T; Wan XR; Yang XY
    Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):83-6. PubMed ID: 15840284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN; Salem HT; Al-Ani AT; Chard T; Huang SC; Ouyang PC; Wei PY; Seppälä M
    Am J Obstet Gynecol; 1981 Mar; 139(6):702-4. PubMed ID: 6971058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM; Seppälä M
    J Clin Endocrinol Metab; 1980 Jan; 50(1):57-61. PubMed ID: 6243133
    [No Abstract]   [Full Text] [Related]  

  • 15. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ; Ruf H; Blanc B; Gamerre M; Adrai J; Conte M; Dupont S; Bellia-Rousseau J
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological origins of discordant chorionic gonadotropin secretion in malignancy.
    Hay DL
    J Clin Endocrinol Metab; 1988 Mar; 66(3):557-64. PubMed ID: 2450890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH; Cannon W; Benedet JL; Boyes DA
    Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary choriocarcinoma of the cervix].
    Abboud J; Attieh E; Afif N; Chalhoub S
    J Gynecol Obstet Biol Reprod (Paris); 1994; 23(2):149-51. PubMed ID: 7518853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of patients with gestational trophoblastic neoplasia based on the antigenic properties of human chorionic gonadotropin.
    Goldstein DP; Nudemberg F; Lymeburner N; Levesque L; Shore C
    J Surg Oncol; 1973; 5(1):1-8. PubMed ID: 4736212
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.